The role of CaMKII regulation of phospholamban activity in heart disease

Frontiers in Pharmacology

Volumn 5 JAN, Issue , 2014, Pages

  Mattiazzi, Alicia ^a   Kranias, Evangelia G ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acidosis; CaMKII; Heart failure; Ischemia reperfusion injury; Myocardium; PLN regulation

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; HAX 1 PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THREONINE; THREONINE 17; UNCLASSIFIED DRUG;

ACIDOSIS; BETA ADRENERGIC STIMULATION; CALCIUM TRANSPORT; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME REGULATION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE REPERFUSION; HUMAN; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SARCOPLASMIC RETICULUM; STUNNED HEART MUSCLE;

EID: 84893511592     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00005     Document Type: Review

References (120)

1. Ai, X., Curran, J. W., Shannon, T. R., Bers, D. M., and Pogwizd, S. M. (2005). Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ. Res. 97, 1314-1322. doi: 10.1161/01.RES.0000194329.41863.89.
2. Allen, D. G., and Orchard, C. H. (1983). The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J. Physiol. (Lond.) 335, 555-567.
3. Arber, S., Hunter, J. J., Ross, J. Jr., Hongo, M., Sansig, G., Borg, J., et al. (1997). MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403. doi: 10.1016/S0092-8674(00)81878-4.
4. Bartel, S., Willenbrock, R., Haase, H., Karczewski, P., Wallukat, G., Dietz, R., et al. (1995). Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes. Biochem. Biophys. Res. Commun. 214, 75-80. doi: 10.1006/bbrc.1995.2258.
5. Bassani, R., Mattiazzi, A., and Bers, D. M. (1995). CaMK-II is responsible for activity-dependent acceleration of relaxation in intact rat ventricular myocytes. Am. J. Physiol. 268, H703-H712.
6. Bers, D. M. (2001). Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd Edn. Dordrecht: Kluwer Academic Publishers. doi: 10.1007/978-94-010-0658-3.
7. Bibb, J. A., Nishi, A., O'Callaghan, J. P., Ule, J., Lan, M., Snyder, G. L., et al. (2001). Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276, 14490-14497.
8. Bilezikjian, L. M., Kranias, E. G., Potter, J. D., and Schwartz, A. (1981). Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase. Circ. Res. 49, 1356-1362. doi: 10.1161/01.RES.49.6.1356.
9. Bluhm, W. F., Kranias, E. G., Dillmann, W. H., and Meyer, M. (2000). Phospholamban: a major determinant of the cardiac force-frequency relationship. Am. J. Physiol. 278, H249-H255.
10. Braunwald, E., and Kloner, R. A. (1982). The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 66, 1146-1149. doi: 10.1161/01.CIR.66.6.1146.
11. Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., et al. (1982). Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307, 205-211. doi: 10.1056/NEJM198207223070401.
12. Carr, A. N., Schmidt, A. G., Suzuki, Y., del Monte, F., Sato, Y., Lanner, C., et al. (2002). Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22, 4124-4135. doi: 10.1128/MCB.22.12.4124-4135.2002.
13. Choi, H. S., Trafford A. W., Orchard, C. H., and Eisner, D. A. (2000). The effect of acidosis on systolic Ca2+ and sarcoplasmic reticulum calcium content in isolated rat ventricular myocytes. J. Physiol. (Lond.) 529, 661-668. doi: 10.1111/j.1469-7793.2000.00661.x.
14. Chu, G., Lester, J. W., Young, K. B., Luo, W., Zhai, J., and Kranias, E. G. (2000). A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists. J. Biol. Chem. 275, 38938-38943. doi: 10.1074/jbc.M004079200.
15. Cingolani, H. E., Mattiazzi, A. R., Blesa, E. S., and González, N. C. (1970). Contractility in isolated mammalian heart muscle after acid base changes. Circ. Res. 26, 269-278. doi: 10.1161/01.RES.26.3.269.
16. Cross, H. R., Kranias, E. G., Murphy, E., and Steenbergen, C. (2003). Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am. J. Physiol. 284, H683-H690.
17. Cutler, M. J., Wan, X., Plummer, B. N., Liu, H., Deschenes, I., Laurita, K. R., et al. (2012). Targeted sarcoplasmic reticulum Ca2+ATPase 2a gene delivery to restore electrical stability in the failing heart. Circulation 126, 2095-2104. doi: 10.1161/CIRCULATIONAHA.111.071480.
18. Dash, R., Kadambi, V., Schmidt, A. G., Tepe, N. M., Biniakiewicz, D., Gerst, M. J., et al. (2001). Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103, 889-896. doi: 10.1161/01.CIR.103.6.889.
19. Davis, B. A., Edes, I., Gupta, R. C., Young, E. F., Kim, H. W., Steenaart, N. A., et al. (1990). The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum. Mol. Cell. Biochem. 99, 83-88. doi: 10.1007/BF00230337.
20. De Koninck, P., and Schulman, H. (1998). Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 279, 227-230. doi: 10.1126/science.279.5348.227.
21. del Monte, F., and Hajjar, R. J. (2003). Targeting calcium cycling proteins in heart failure through gene transfer. J. Physiol. (Lond.) 546, 49-61. doi: 10.1113/jphysiol.2002.026732.
22. del Monte, F., Harding, S. E., Dec, G. W., Gwathmey, J. K., and Hajjar, R. J. (2002). Targeting phospholamban by gene transfer in human heart failure. Circulation 105, 904-907. doi: 10.1161/hc0802.105564.
23. del Monte, F., Harding, S. E., Schmidt, U., Matsui, T., Kang, Z. B., Dec, G. W., et al. (1999). Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100, 2308-2311. doi: 10.1161/01.CIR.100.23.2308.
24. DeSantiago, J., Maier, L. S., and Bers, D. M. (2002). Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J. Mol. Cell Cardiol. 34, 975-984. doi: 10.1006/jmcc.2002.2034.
25. DeSantiago, J., Maier, L. S., and Bers, D. M. (2004). Phospholamban is required for CaMKII-dependent recovery of Ca transients and SR Ca reuptake during acidosis in cardiac myocytes. J. Mol. Cell Cardiol. 36, 67-74. doi: 10.1016/j.yjmcc.2003.10.012.
26. Domenech, R. J., Sánchez, G., Donoso, P., Parra, V., and Macho, P. (2003). Effect of tachycardia on myocardial sarcoplasmic reticulum and Ca2+dynamics: a mechanism for preconditioning? J. Mol. Cell Cardiol. 35, 1429-1437. doi: 10.1016/j.yjmcc.2003.09.006.
27. Edes, I., and Kranias, E. G. (1990). Phospholamban and troponin I are substrates for protein kinase C in vitro but not in intact beating guinea pig hearts. Circ. Res. 67, 394-400. doi: 10.1161/01.RES.67.2.394.
28. Fabiato, A., and Fabiato, F. (1977). Calcium release from the sarcoplasmic reticulum. Circ. Res. 40, 119-129. doi: 10.1161/01.RES.40.2.119.
29. Fabiato, A., and Fabiato, F. (1978). Myofilament-generated tension oscillations during partial calcium activation and activation dependence of the sarcomere length-tension relation of skinned cardiac cells. J. Gen. Physiol. 72, 667-6 99.
30. Gupta, R. C., Mishra, S., Rastogi, S., Imai, M., Habib, O., and Sabbah, H. N. (2003). Cardiac SR-coupled PP1 and expression are increased and inhibitor-1 protein expression is decreased in failing hearts. Am. J. Physiol. 285, H2373-H2381.
31. Gupta, R. C., Neumann, J., Watanabe, A. M., Lesch, M., and Sabbah, H. N. (1996). Evidence for presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocyte. Am. J. Physiol. 270, H1159-H1164.
32. Hagemann, D., Kuschel, M., Kuramochi, T., Zhu, W., Cheng, H., and Xiao, R.-P. (2000). Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J. Biol. Chem. 275, 22532-22536. doi: 10.1074/jbc.C000253200.
33. Harrison, S. M., Frampton, J. E., McCall, E., Boyett, M. R., and Orchard, C. H. (1992). Contraction and intracellular Ca2+, Na+ and H+ during acidosis in rat ventricular myocytes. Am. J. Physiol. 262, C348-C357.
34. Hasenfuss, G. (1998). Alterations in calcium regulatory proteins in heart failure. Cardiovasc. Res. 37, 279-289. doi: 10.1016/S0008-6363(97)00277-0.
35. Hidalgo, C., Bull, R., Behrens, M. I., and Donoso, P. (2004). Redox regulation of RyR-mediated Ca2+ release in muscle and neurons. Biol. Res. 37, 539-552. doi: 10.4067/S0716-97602004000400007.
36. Hoit, B. D., Khoury, S. F., Kranias, E. G., Ball, N., and Walsh, R. A. (1995). In vivo echocardiographic detection of enhanced left ventricular function in gene targeted mice with phospholamban deficiency. Circ Res. 77, 632-637. doi: 10.1161/01.RES.77.3.632.
37. Huang, B., Wang, S., Qin, D., Boutjdir, M., and El-Sherif, N. (1999). Dimished basal phosphorylation level of phospholamban in the postinfarctium remodeled rat ventricle. Role of beta adrenergic pathway, Gi protein, phosphodiesterase and phosphatases. Circ. Res. 85, 848-855. doi: 10.1161/01.RES.85.9.848.
38. Huggins, J. P., Cook, E. A., Piggott, J. R., Mattinsley, T. J., and England, P. J. (1989). Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle. Biochem. J. 260, 829-835.
39. Huke, S., and Bers, D. M. (2007). Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. J. Mol. Cell Cardiol. 42, 590-599. doi: 10.1016/j.yjmcc.2006.12.007.
40. Iyer, R. B., Koritz, S. B., and Kirchberger, M. A. (1988). A regulation of the level of phosphorylated phospholamban by inhibitor-1 in rat heart preparations in vitro. Mol. Cell. Endocrinol. 55, 1-6. doi: 10.1016/0303-7207(88)90084-6.
41. James, P., Inui, M., Tada, M., Chiesi, M., and Carafoli, E. (1989). Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature 342, 90-92. doi: 10.1038/342090a0.
42. Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., et al. (2009). Calcium up-regulation by percutaneous administration of gene therapy in cardiac disease (CUPID) trial investigators. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-inhuman phase 1/2 clinical trial. J. Card. Fail. 15, 171-181. doi: 10.1016/j.cardfail.2009.01.013.
43. Ji, J., Zhao, W., Li, B., Desantiago, J., Picht, E., Kaetzel, M., et al. (2006). Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility. Am. J. Physiol. 290, H599-H606.
44. Joiner, M. A., Kovall, O. M., Li, J., He, B. J., Allamargot, C., Gao, Z., et al. (2012). CaMKII determines mitochondrial stress responses in heart. Nature 491, 269-274. doi: 10.1038/nature11444.
45. Kadambi, V. J., Ponniah, S., Harrer, J., Hoit, B., Dorn, G. W., Walsh, R. A., et al. (1996). Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97, 533-539. doi: 10.1172/JCI118446.
46. Kim, H. W., Steenaart, N. A., Ferguson, D. G., and Kranias, E. G. (1990). Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2+-ATPase with phospholamban in phospholipid vesicles. J. Biol. Chem. 265, 1702-1709.
47. Kirchberger, M. A., Tada, M., Repke, D. I., and Katz, A. M. (1972). Cyclic adenosine 3', 5'-monophosphate dependent protein kinase stimulation of calcium uptake by canine cardiac microsomes. J. Mol. Cell Cardiol. 4, 673-680. doi: 10.1016/0022-2828(72)90120-4.
48. Komukai, K., Pascarel, C., and Orchard, C. H. (2001). Compensatory role of CaMKII on ICa and SR function during acidosis in rat ventricular myocytes. Pflügers Arch. 442, 353-361. doi: 10.1007/s004240100549.
49. Kranias, E. G. (1985). Regulation of calcium transport by protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J. Biol. Chem. 260, 11006-11010.
50. Kuschel, M., Karczewski, P., Hempel, P., Schlegel, W. P., Krause, E. G., and Bartel, S. (1999). Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation. Am. J. Physiol. 276, H1625-H1633.
51. Lam, C. K., Zhao, W., Cai, W., Vafiadaki, E., Florea, S. M., Ren, X., et al. (2013). Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90. Circ. Res. 112, 79-89. doi: 10.1161/CIRCRESAHA.112.279935.
52. Lindemann, J. P., and Watanabe, A. M. (1985). Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms. J. Biol. Chem. 260, 4516-4525.
53. Lindemann, J. P., Jones, L. R., Hathaway, D. R., Henry, B. G., and Watanabe, A. M. (1983). β-adrenergic simulation of phospholamban phosphorylation and Ca2+-ATPase activity in guine pig ventricles. J. Biol. Chem. 258, 464-471.
54. Luo, W., Chu, G., Sato, Y., Zhou, Z., Kadambi, V. J., and Kranias, E. G. (1998). Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J. Biol. Chem. 273, 4734-4739. doi: 10.1074/jbc.273.8.4734.
55. Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., et al. (1994). Targeted ablation of the phospholamban gene is associatied with markedly enhanced myocardial contractility and loss of β-agonist simulation. Circ. Res. 75, 401-409. doi: 10.1161/01.RES.75.3.401.
56. Luo, W., Wolska, B. M., Grupp, I. L., Harrer, J. M., Haghighi, K., Ferguson, D. G., et al. (1996). Phospholamban gene dosage effects in the mammalian heart. Circ. Res. 78, 839-847. doi: 10.1161/01.RES.78.5.839.
57. MacDougall, L. K., Jones, L. R., and Cohen, P. (1991). Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196, 725-734. doi: 10.1111/j.1432-1033.1991.tb15871.x.
58. Mandel, F., Kranias, E. G., de Gende, A. G., Sumida, M., and Schwart, A. (1982). The effect of pH on the transient-state kinetics of Ca2+-Mg2+-ATPase of cardiac sarcoplasmic reticulum. Circ. Res. 50, 310-317. doi: 10.1161/01.RES.50.2.310.
59. Mattiazzi, A., and Cingolani, H. E. (1977a). Biphasic effect of hypercapnia on myocardial contractility. Arch. Int. Physiol. Biochim. 85, 11-25.
60. Mattiazzi, A., and Cingolani, H. E. (1977b). Paradoxical effect of hypercapnia on toad ventricular muscle. Circ. Res. 41, 117-122. doi: 10.1161/01.RES.41.1.117.
61. Meyer, M., Schillinger, W., Pieske, B, Holubarsch, C., Heilmann, C., Posival, H., et al. (1995). Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92, 778-784. doi: 10.1161/01.CIR.92.4.778.
62. Minamisawa, S., Hoshijima, M., Chu, G., Ward, C. A., Frank, K., Gu, Y., et al. (1999). Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313-322. doi: 10.1016/S0092-8674(00)81662-1.
63. Mishra, S., Sabbah, H. N., Jain, J. C., and Gupta, R. C. (2003). Reduced Ca2+-calmodulin-dependent protein kinase activity and expression of LV myocardium of dogs with heart failure. Am. J. Physiol. 284, H876-H883.
64. Movsesian, M. A., Nishikawa, M., and Adelstein, R. S. (1984). Phosphorylation of phospholamban by calcium-activated, phospholipid-dependent protein kinase. Stimulation of cardiac sarcoplasmic reticulum calcium uptake. J. Biol. Chem. 259, 8029-8032.
65. Münch, G., Bölck, B., Karczewski, P., and Schwinger, R. H. (2002). Evidence for calcineurin-mediated regulation of SERCA2a activity in human myocardium. J. Mol. Cell Cardiol. 34, 321-334. doi: 10.1006/jmcc.2001.1515.
66. Mundiña-Weilenmann, C., Ferrero, P., Said, M., Vittone, L., Kranias, E. G., and Mattiazzi, A. (2005). Role of phosphorylation of Thr17 residue of phospholambanin mechanical recovery during hypercapnic acidosis. Cardiovasc. Res. 66, 114-122. doi: 10.1016/j.cardiores.2004.12.028.
67. Mundiña-Weilenmann, C., Vittone, L., Ortale, M., Chiappe de Cingolani, G., and Mattiazzi, A. (1996). Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J. Biol. Chem. 271, 33561-33567. doi: 10.1074/jbc.271.52.33561.
68. Napolitano, R., Vittone, L., Mundiña Weilenmann, C., Chiappe de Cingolani, G., and Mattiazzi, A. (1992). Phosphorylation of phospholamban in the intact heart. A study on the physiological role of the Ca-calmodulin-dependent protein kinase system. J. Mol. Cell Cardiol. 24, 387-396. doi: 10.1016/0022-2828(92)93193-N.
69. Neef, S., Sag, C. M., Daut, M., Bäumer, H., Grefe, C., El-Armouche A, et al. (2013). While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMKIId-KO mice. J. Mol. Cell Cardiol. 59, 107-116. doi: 10.1016/j.yjmcc.2013.02.014.
70. Netticadan, T., Temsah, R., Kawabata, K., and Dallha, NS. (2000). Sarcoplasmic reticulum Ca2+/calmodulin-dependent kinase is altered in heart failure. Circ. Res. 86, 596-605. doi: 10.1161/01.RES.86.5.596.
71. Neumann, J., Gupta, R. C., Schmitz, W., Scholz, H., Nairn, A. C., and Watanabe, A. M. (1991). Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ. Res. 69, 1450-1457. doi: 10.1161/01.RES.69.6.1450.
72. Nicolaou, P., Rodriguez, P., Ren, X., Zhou, X., Qian, J., Sadayappan, S., et al. (2009). Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circ. Res. 104, 1012-1020. doi: 10.1161/CIRCRESAHA.108.189811.
73. Nomura, N., Satoh, H., Terada, H., Matsunaga, M., Watanabe, H., and Hayashi, H. (2002). CaMKII-dependent reactivation of SR Ca2+ uptake and contractile recovery during intracellular acidosis. Am. J. Physiol. 283, H193-H203.
74. O'Rourke, B., Kass, D. A., Tomaselli, G. F., Kääb, S., Tunin, R., and Marbán, E. (1999). Mechanisms of altered excitation-contraction coupling in canine tachicardia-induced heart failure. I. Experimental studies. Circ. Res. 84, 562-570. doi: 10.1161/01.RES.84.5.562.
75. Oestreich, E. A., Malik, S., Goonasekera, S. A., Blaxall, B. C., Kelley, G. G., Dirksen, R. T., et al. (2009). Epac and phospholipase Ce regulate Ca2+ release in the heart by activation of protein kinase Ce and calcium-calmodulin kinase II. J. Biol. Chem. 284, 1514-1522. doi: 10.1074/jbc.M806994200.
76. Oestreich, E. A., Wang, H., Malik, S., Kaproth-Joslin, K. A., Blaxall, B. C., Kelley, G. G., et al. (2007). Epac-mediated activation of phospholipase Ce plays a critical role in β-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. J. Biol. Chem. 282, 5488-5495. doi: 10.1074/jbc.M608495200.
77. Orchard, C. H., Houser, S. R., Kort, A. A., Bahinski, A., Capogrossi, M. C., and Lakatta, E. G. (1987). Acidosis facilitates spontaneous sarcoplasmic reticulum Ca2+ release in rat myocardium. J. Genet. Physiol. 90, 145-165. doi: 10.1085/jgp.90.1.145.
78. Orchard, C. H., and Kentish, J. C. (1990). Effects of changes of pH on the contractile function of cardiac muscle. Am. J. Physiol. 258, C967-C981.
79. Pedrozo, Z., Sánchez, G., Torrealba, N., Valenzuela, R., Fernández, C., Hidalgo, C., et al. (2010). Calpains and proteasomes mediate degradation of ryanodine receptors in a model of cardiac ischemic reperfusion. Biochim. Biophys. Acta 1802, 356-362. doi: 10.1016/j.bbadis.2009.12.005.
80. Pereira, L., Cheng, H., Lao, D. H., Na, L., van Oort, R. J., Brown, J. H., et al. (2013). Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation 127, 913-922. doi: 10.1161/CIRCULATIONAHA.12.148619.
81. Pereira, L., Metrich, M., Fernández-Velasco, M., Lucas, A., Leroy, J., Perrier, R., et al. (2007). The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J. Physiol. 583, 685-694. doi: 10.1113/jphysiol.2007.133066.
82. Pérez, N. G., Mattiazzi, A. Camilion de Hurtado, M. C., and Cingolani, H. E. (1995). Myocardial contractility recovery during hypercapnic acidosis: its dissociation from recovery in pHi by ryanodine. Can. J. Cardiol. 11, 553-560.
83. Philipson, K. D., Bersohn, M. M., and Nishimoto, A. Y. (1982). Effects of pH on Na+-Ca2+ exchange in canine sarcolemmal vesicles. Circ. Res. 50, 287-293. doi: 10.1161/01.RES.50.2.287.
84. Piacentino, V. III, Weber, C. R., Chen, X., Weisser-Thomas, J., Margulies, K. B., Bers, D. M., et al. (2003). Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 92, 651-658. doi: 10.1161/01.RES.0000062469.83985.9B.
85. Picht, E., DeSantiago, J., Huke, S., Kaetzel, M. A., Dedman, J. R., and Bers, D. M. (2007). CaMKII inhibition targeted to the sarcoplasmic reticulum inhibits frequency-dependent acceleration of relaxation and Ca2+ current facilitation. J. Mol. Cell Cardiol. 42, 196-205. doi: 10.1016/j.yjmcc.2006.09.007.
86. Poole-Wilson, P. A. (1989). Regulation of intracellular pH in the myocardium; relevance to pathology. Mol. Cell. Biochem. 89, 151-155. doi: 10.1007/BF00220768.
87. Port, J. D., and Bristow, M. R. (2001). Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell Cardiol. 33, 887-905. doi: 10.1006/jmcc.2001.1358.
88. Qian, J., Vafiadaki, E., Florea, S., Singh, V., Song, W., Lam, C. K., et al. (2011). Small heat shock protein 20 interacts with protein phosphatise-1 and enhances sarcoplasmic reticulum calcium cycling. Circ. Res. 108, 1429-1438. doi: 10.1161/CIRCRESAHA.110.237644.
89. Respress, J. L., van Oort, R. J., Li, N., Rolim, N., Dixit, S. S, deAlmeida, A., et al. (2012). Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474-1483. doi: 10.1161/CIRCRESAHA.112.268094.
90. Rizzuto, R., and Pozzan, T. (2006). Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol. Rev. 86, 369-408. doi: 10.1152/physrev.00004.2005.
91. Said, M., Becerra, R., Palomeque, J., Rinaldi, G., M. Kaetzel, M. A., Diaz-Sylvester, P. L., et al. (2008). Increased intracellular Ca2+ and SR Ca2+ load contribute to arrhythmias after acidosis in rat heart. Role of Ca2+/calmodulin-dependent protein kinase II. Am. J. Physiol. 295, H1669-H1683. doi: 10.1152/ajpheart.00010.2008.
92. Said, M., Becerra, R., Valverde, C. A., Kaetzel, M. A., Dedman, J. R., Mundiña-Weilenmann, C., et al. (2011). Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias. J. Mol. Cell Cardiol. 51, 936-944. doi: 10.1016/j.yjmcc.2011.08.010.
93. Said, M., Mundiña-Weilenmann, C., Vittone, L., and Mattiazzi, A. (2002). The relative relevance of phosphorylation of the Thr17 residue of phospholamban is different at different levels of β-adrenergic stimulation. Pflügers Arch. 444, 801-809. doi: 10.1007/s00424-002-0885-y.
94. Said, M., Vittone, L., Mundiña-Weilenmann, C., Ferrero, P., Kranias, E. G., and Mattiazzi, A. (2003). Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants. Am. J. Physiol. 285, H1198-H1205. doi: 10.1152/ajpheart.00209.2003.
95. Salas, M. A., Valverde, C. A., Sánchez, G., Said, M., Rodriguez, J. S., Portiansky, E. L., et al. (2010). The signaling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury. J. Mol. Cell Cardiol. 48, 1298-1306. doi: 10.1016/j.yjmcc.2009.12.015.
96. Sande, J. B., Sjaastad, I., Hoen, I. B., Bokenes, J., Tonnessen, T., Holt, E., et al. (2002). Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 53, 383-391. doi: 10.1016/S0008-6363(01)00489-8.
97. Schwinger, R. H., Munch, G., Bolk, B., Karczewski, P., Krause, E-G., and Erdmann, E. (1999). Reduced Ca2+-sensitivity of SERCA2a in failing human myocardium due to reduced Serin-16 phospholamban phosphorylation. J. Mol. Cell Cardiol. 31, 479-491. doi: 10.1006/jmcc.1998.0897.
98. Shan, J., Betzenhauser, M. J., Kushnir, A., Reiken, S., Meli, A. C., Wronska, A., et al. (2010). Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. J. Clin. Invest. 120, 4375-4387. doi: 10.1172/JCI37649.
99. Simmerman, H. K. B., and Jones, L. R. (1998). Phospholamban: protein structure, mechanism of action and role in cardiac function. Physiol. Rev. 78, 921-947.
100. Simmerman, H. K., Collins, J. H., Theibert, J. L., Wegener, A. D., and Jones, L. R. (1986). Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J Biol Chem. 61, 13333-13341.
101. Tada, M., Kirchberger, M. A., and Katz, A. M. (1975). Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3',5'-monophosphate-dependet protein kinase. J. Biol. Chem. 250, 2640-2647.
102. Talukder, M. A., Kalyanasundaram, A., Zhao, X., Zuo, L., Bhupathy, P., Babu, G. J., et al. (2007). Expression of SERCA isoform with faster Ca2+-transport properties improves post-ischemic cardiac function and Ca2+-handling and decreases myocardial infarction. Am. J. Physiol. 293, H2418-H2428.
103. Talukder, M. A., Kalyanasundaram, A., Zuo, L., Velayutham, M., Nishijima, Y., Periasamy, M., et al. (2008). Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice. Am. J. Physiol. 294, H1426-H1434. doi: 10.1152/ajpheart.01016.2007.
104. Vafiadaki, E., Sanoudou, D., Arvanitis, D. A., Catino, D. H., Kranias, E. G., and Kontrogianni-Konstantopoulos, A. (2007). Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. J. Mol. Biol. 367, 65-79. doi: 10.1016/j.jmb.2006.10.057.
105. Valverde, C. A., Di Carlo, M. N., Said, M., Wehrens, X. H., Salas, M., and Mattiazzi, A. (2013). Phosphorylation of ryanodine receptors (RyR2) is a key player in the ischemia/reperfusion-induced infarct size and decrease in cardiac function. J. Mol. Cell Cardiol. 65(Suppl.), S109.
106. Valverde, C. A., Kornyeyev, D., Ferreiro, M., Petrosky, A. D., Mattiazzi, A., and Escobar, A. L. (2010). Transient Ca2+ depletion of the sarcoplasmic reticulum at the onset of reperfusion. Cardiovasc. Res. 85, 671-680. doi: 10.1093/cvr/cvp371.
107. Valverde, C. A., Mundiña-Weilenmann, C., Reyes, M., Kranias, E. G., Escobar, A. L., and Mattiazzi, A. (2006). Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart. Cardiovasc. Res. 70, 335-345. doi: 10.1016/j.cardiores.2006.01.018.
108. Valverde, C., Mundiña-Weilenmann, C., Said, M., Ferrero, P., Vittone, L., Salas, M., et al. (2005). Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J. Physiol. (Lond.) 562, 801-813. doi: 10.1113/jphysiol.2004.075432.
109. Vila-Petroff, M., Mundiña-Weilenmann, C., Lezcano, N., Snabaitis, A. K., Huergo, M. A., Valverde, C. A., et al. (2010). Ca(2+)/calmodulin-dependent protein kinase II contributes to intracellular pH recovery from acidosis via Na(+)/H(+) exchanger activation. J. Mol. Cell Cardiol. 49, 106-112. doi: 10.1016/j.yjmcc.2009.12.007.
110. Vila-Petroff, M., Salas, M., Said, M., Valverde, C. A., Sapia, L., Portiansky, E., et al. (2007). CaMKII-Inhibition Protects against Necrosis and Apoptosis in the Irreversible Ischemia-Reperfusion Injury. Cardiovasc. Res. 73, 689-698. doi: 10.1016/j.cardiores.2006.12.003.
111. Vittone, L., Mundiña-Weilenmann, C., Chiappe de Cingolani, G., and Mattiazzi, A. (1990). cAMP and calcium dependent mechanisms of phospholamban phosphorylation in intact hearts. Am. J. Physiol. 258, H318-H325.
112. Vittone, L., Mundiña-Weilenmann, C., Said, M., and Mattiazzi, A. (1998). Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart. J. Biol. Chem. 273, 9804-9811. doi: 10.1074/jbc.273.16.9804.
113. Vittone, L., Mundiña-Weilenmann, C., Said, M., Ferrero, P., and Mattiazzi, A. (2002). Time course and mechanisms of phosphorylation of phospholamban residues in ischemia reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways. J. Mol. Cell Cardiol. 34, 39-50. doi: 10.1006/jmcc.2001.1488.
114. Wang, W., Zhu, W., Wang, S., Yang, D., Crow, M. T., Xiao, R.-P., and Cheng, H. (2004). Sustained β1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ. Res. 95, 798-806. doi: 10.1161/01.RES.0000145361.50017.aa.
115. Wu, Y., Luczak, E. D., Lee, E.-J., Hidalgo, C., Yang, J., Gao, Z., et al. (2012). CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban. J. Mol. Cell Cardiol. 53, 429-436. doi: 10.1016/j.yjmcc.2012.06.019.
116. Yang. Y., Zhu, W. Z., Joiner, M. L., Zhang, R., Oddis, C. V., Hou, Y., et al. (2006). Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol. 291, H3065-H3075.
117. Zhang, R., Khoo, M. S., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., et al. (2005). Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11, 409-417. doi: 10.1038/nm1215.
118. Zhang, T., Guo, T., Mishra, S., Dalton, N. D., Kranias, E. G., Peterson, K. L., et al. (2010). Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdeltaC transgenic mice. Circ. Res. 106, 354-362. doi: 10.1161/CIRCRESAHA.109.207423.
119. Zhao, W., Uehara, Y., Chu, G., Song, Q., Qian, J., Young, K., et al. (2004). Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. J. Mol. Cell Cardiol. 37, 607-612. doi: 10.1016/j.yjmcc.2004.05.013.
120. Zhao, W., Waggoner, J. R., Zhang, Z. G., Lam, C. K., Han, P., Qian, J., et al. (2009). The anti-apoptotic protein HAX-1 is a novel regulator of cardiac function. Proc. Natl. Acad. Sci. U.S.A. 106, 20776-20781. doi: 10.1073/pnas.0906998106.